Does simultaneous antegrade and retrograde cardioplegia improve functional recovery and myocardial homeostasis?

M J Jasinski1, S Wos, Z Kadziola

  • 1Department of Cardiothoracic Surgery, Glenfield Hospital, Leicester, United Kingdom. marek.jasinski@glenfield-tr.trent.nhs.uk

Insights

Simultaneous antegrade and retrograde cardioplegia better preserves myocardial oxygen utilization and functional recovery compared to retrograde alone. Anaerobic metabolism markers showed no significant difference between the two methods.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Anesthesia
  • Myocardial Protection

Background:

  • Myocardial preservation is critical during cardiac surgery.
  • Different cardioplegia techniques aim to optimize myocardial protection.

Purpose of the Study:

  • To compare functional recovery and homeostasis of the myocardium.
  • Evaluate simultaneous continuous antegrade and retrograde cardioplegia versus continuous retrograde cardioplegia.

Main Methods:

  • Prospective study of 40 patients undergoing coronary artery bypass grafting (CABG).
  • Two groups: continuous retrograde cardioplegia (n=24) and simultaneous antegrade/retrograde cardioplegia (n=16).
  • Measured myocardial oxygen utilization, anaerobic metabolism markers, and cardiac function parameters.

Main Results:

  • Simultaneous cardioplegia showed better recovery of myocardial oxygen content and extraction post-cross-clamping.
  • No significant differences in hydrogen ion, carbon dioxide, or lactate release between groups.
  • A trend towards better left ventricle stroke work index recovery was observed in the simultaneous group.

Conclusions:

  • Simultaneous antegrade and retrograde cardioplegia appears advantageous for preserving myocardial viability and function.
  • No difference in anaerobic metabolism markers suggests similar protection against anaerobic damage.
  • This technique may offer superior myocardial protection over retrograde cardioplegia alone.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...